BIAF · bioAffinity Technologies, Inc. · Exempt Offerings
$1.76
-0.09 (-4.86%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current expected level of operating expenditures, current expected levels of revenue, and the cash and cash equivalents on hand at September 30, 2026, of $2.6 million, management concludes that there is substantial doubt about our ability to continue as a going concern for a period of at least twelve (12) months subsequent to the issuance of the accompanying unaudited condensed consolidated financial statements contained in this Quarterly Report.”View the 10-Q filed Nov 6, 2026
Market Cap
$3.37M
Shares
1.82M
Volume · Nov 20
16.77K
Avg daily vol (63 sessions)
3.6M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1712762
CUSIP
09076W406
13F (30d)
21 filings
14 filers
Visit website
Investor relations